DK1500395T3 - Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser - Google Patents

Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser

Info

Publication number
DK1500395T3
DK1500395T3 DK04025513T DK04025513T DK1500395T3 DK 1500395 T3 DK1500395 T3 DK 1500395T3 DK 04025513 T DK04025513 T DK 04025513T DK 04025513 T DK04025513 T DK 04025513T DK 1500395 T3 DK1500395 T3 DK 1500395T3
Authority
DK
Denmark
Prior art keywords
reboxetine
fibromyalgia
treatment
somatoform disorders
somatoform
Prior art date
Application number
DK04025513T
Other languages
English (en)
Inventor
Saeeduddin Ahmed
Lars Birgerson
Pasquale Cetera
Robert Clyde Marshall
Robert Mcarthur
Duncan P Taylor
Erik H F Wong
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32831120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1500395(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Priority claimed from EP00941659A external-priority patent/EP1196172B1/en
Application granted granted Critical
Publication of DK1500395T3 publication Critical patent/DK1500395T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK04025513T 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser DK1500395T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14196899P 1999-07-01 1999-07-01
US14413199P 1999-07-16 1999-07-16
US15825699P 1999-10-06 1999-10-06
US17038199P 1999-12-13 1999-12-13
EP00941659A EP1196172B1 (en) 1999-07-01 2000-06-22 (S,S)-Reboxetine for treating chronic pain

Publications (1)

Publication Number Publication Date
DK1500395T3 true DK1500395T3 (da) 2006-06-19

Family

ID=32831120

Family Applications (5)

Application Number Title Priority Date Filing Date
DK04013379T DK1459748T3 (da) 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati
DK04013383T DK1459751T3 (da) 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine
DK04025513T DK1500395T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04025514T DK1500396T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK04013379T DK1459748T3 (da) 1999-07-01 2000-06-22 (S,S)-reboxetin til behandling af perifer neuropati
DK04013383T DK1459751T3 (da) 1999-07-01 2000-06-22 (S,S)reboxetin til behandling af migrænehovedpine

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK04023888T DK1493442T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af perifer neuropati
DK04025514T DK1500396T3 (da) 1999-07-01 2000-06-22 Reboxetin til behandling af migrænehovedpiner

Country Status (3)

Country Link
EP (10) EP1459751B1 (da)
DK (5) DK1459748T3 (da)
SI (1) SI1196172T1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070029740A (ko) * 2004-06-09 2007-03-14 화이자 인코포레이티드 통증 치료를 위한 레복세틴의 용도
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
CA2304112A1 (en) * 1997-09-23 1999-04-01 John Harrison Heiligenstein Treatment of attention-deficit/hyperactivity disorder
UA57107C2 (uk) * 1997-09-23 2003-06-16 Елі Ліллі Енд Компані Спосіб лікування розладу поведінки
CZ297346B6 (cs) * 1998-04-09 2006-11-15 Pharmacia & Upjohn Company Pouzití reboxetinu pro výrobu léku k lécbe nervových poruch
IT1305322B1 (it) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Uso di reboxetina per il trattamento di disturbi nervosi
DE69922367T2 (de) * 1998-05-08 2005-12-22 Pharmacia & Upjohn Co., Kalamazoo Neue arzneimittelkombinationen aus reboxetin und pindolol
BR9912508A (pt) * 1998-06-29 2001-05-02 Pharmaceuticals Applic Associa Métodos e composições transdérmicas para alìvio da dor
SE9904750D0 (sv) * 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
PT1257277E (pt) * 2000-02-24 2005-09-30 Pharmacia & Upjohn Co Llc Novas combinacoes de farmacos

Also Published As

Publication number Publication date
EP1500396A1 (en) 2005-01-26
EP1459748A1 (en) 2004-09-22
SI1196172T1 (sl) 2006-06-30
DK1493442T3 (da) 2005-12-19
EP1493442A1 (en) 2005-01-05
EP1500395B1 (en) 2006-03-08
EP1629843A3 (en) 2006-03-15
EP1459751A1 (en) 2004-09-22
DK1459751T3 (da) 2005-12-19
DK1500396T3 (da) 2005-12-19
EP1459748B1 (en) 2005-04-13
EP1493442B1 (en) 2005-09-28
EP1459748B8 (en) 2005-06-08
EP1459750B1 (en) 2005-06-01
EP1629843A2 (en) 2006-03-01
EP1459751B1 (en) 2005-09-14
EP1632234A2 (en) 2006-03-08
EP1632235A3 (en) 2006-06-14
EP1500395A1 (en) 2005-01-26
EP1459749B1 (en) 2005-10-05
EP1500396B1 (en) 2005-09-28
EP1632234A3 (en) 2006-03-15
EP1459750A1 (en) 2004-09-22
EP1459749A1 (en) 2004-09-22
EP1632234B1 (en) 2007-06-13
DK1459748T3 (da) 2005-07-04
EP1632235A2 (en) 2006-03-08

Similar Documents

Publication Publication Date Title
DK1459750T3 (da) (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
IS2457B (is) Samsetningar af lyfjum (t.d. klórprómasíni og pentamídíni) fyrir meðhöndlun á æxlistruflunum
DK1352897T3 (da) Adamantanderivater til behandlingen af inflammatoriske sygdomme, immunsygdomme og cardiovaskulære sygdomme
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1212317T3 (da) Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser
DK1109453T3 (da) Sammensætninger og fremgangsmåder til behandling af mitokondrielle sygdomme
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
IS5720A (is) Latar gegn peptídýli af VLA-4 skilyrtri frumutengingu gagnlegir til meðhöndlunar á bólguvaldandi-, sjálfónæmis, og öndunarsjúkdómum
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
DK199900790A (da) Fremgangsmåde og anlæg til behandling af mælk
DK1176964T3 (da) Brug af ET743 til behandling af cancer
DK1228028T3 (da) Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
DK2189162T3 (da) Fremgangsmåder til behandling af cellulære proliferative forstyrrelser
DK199800837A (da) Anlæg til behandling af emner
DK1381382T3 (da) Fremgangsmåder og præparater til behandling af öjensygdomme
DK1355936T3 (da) Polymerkonjugater af neublastin og fremgangsmåder til anvendelse af samme
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
DK1392355T3 (da) Anvendelse af proteasominhibitorer tilbehandling af öjentörhedslidelser
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20052264D0 (no) Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser
DK1267847T3 (da) 5HT2-antagonist til regulering af IOP og behandling af glaucom
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse